About Ratnagene Lifescience Private Limited
Data last updated:
Ratnagene Lifescience Private Limited was a private limited company based in Ahmedabad, Gujarat, India, operated as a subsidiary of Senores Pharmaceuticals Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 September 2021.
The company was registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ2021PTC125613. Its GSTIN is 24AALCR2853E1ZF (Gujarat).
The company had an authorised share capital of ₹9 Cr and a paid-up capital of ₹6.86 Cr. It was led by directors including Swapnil Jatinbhai Shah and Chetan Bipinchandra Shah.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at Ahmedabad, Gujarat.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.98 Cr. For the same year it recorded a net loss of ₹30.71 Lakh (net margin -15.5%) and EBITDA of ₹55,000 (EBITDA margin 0.3%).
The company had about 45 employees on its provident fund (EPFO) records before it was dissolved.
As per MCA filings, the company had open charges of ₹77.25 Cr on record.
The last known website on record is ratnagene.com.
Company details
Contact details
Ratnagene Lifescience Private Limited's registered office is in Ahmedabad, Gujarat. Its website is ratnagene.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1004 – 1006 10th Floor North Tower, Off. Ambli Road Opp. Ashok Vatika, Ahmedabad, Gujarat, India – 380054
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ratnagene Lifescience Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ratnagene Lifescience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ratnagene Lifescience Private Limited, buy the company report.
Financials of Ratnagene Lifescience Private Limited
FY 2023 filings availableRatnagene Lifescience Private Limited reported revenue of ₹1.98 Cr for FY 2023.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ₹1.98 Cr | |
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹55,000 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹30.71 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 0.3% | |
| Net Profit Margin | -15.5% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Ratnagene Lifescience Private Limited, buy the company report.
Board of directors of Ratnagene Lifescience Private Limited
Ratnagene Lifescience has 5 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swapnil Jatinbhai Shah Also directs: Senores Pharmaceuticals Limited, Espee Therapeutics LLP, Aelius Projects LLP and 5 more | Director | 15 Sep 2021 | 5 Years 1 Months | As last reported |
| Chetan Bipinchandra Shah | Director | 05 Feb 2024 | 2 Years 9 Months | As last reported |
| Rishabh Mahendrakumar Sanghvi | Director | 15 Sep 2021 | 5 Years 1 Months | As last reported |
| Deval Rajnikant Shah Also directs: Senores Pharmaceuticals Limited | Director | 05 Feb 2024 | 2 Years 9 Months | As last reported |
| Vinay Khandelwal Also directs: Vitex Laboratories Private Limited, Aukea Life Sciences Private Limited, Auracare Pharma Private Limited and 1 more | Director | 01 Sep 2022 | 4 Years 2 Months | As last reported |
Peer comparison
Ratnagene Lifescience Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Waruksha Laboratories Private Limited | ₹2.03 Cr (FY 2025) | -5.0% | Sanand, Gujarat, India | |||
| Vidgas Science & Technologies Private Limited | ₹1.99 Cr (FY 2025) | 218.0% | Hyderabad, Telangana, India | |||
| Richcore Enzymes Private Limited | ₹1.98 Cr (FY 2015) | 59.0% | Bangalore, Karnataka, India | |||
| Ratnagene Lifescience Private Limitedthis company | ₹1.98 Cr (FY 2023) | -₹30.71 Lakh | -15.5% | 45 | Ahmedabad, Gujarat, India | |
| Tooba Pharmaceuticals Private Limited | ₹1.97 Cr (FY 2024) | 57.0% | Aurangabad, Maharashtra, India | |||
| Noven Life Sciences Private Limited | ₹1.95 Cr (FY 2024) | -38.0% | Hyderabad, Telangana, India | |||
| Venkatasai Lifesciences Private Limited | ₹1.85 Cr (FY 2025) | Hyderabad, Telangana, India |
To see the full peer comparison of Ratnagene Lifescience Private Limited, buy the company report.
Auditor
Ratnagene Lifescience Private Limited is audited by Parikh & Majmudar for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Parikh & Majmudar | FY 2023 | 107525W |
Shareholding
The shareholding of Ratnagene Lifescience Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Ratnagene Lifescience Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Jun 2023 | 100762760 | Hdfc Bank Limited | ₹40 Cr | Open | |
| 03 Apr 2023 | 100706667 | Hdfc Bank Limited | ₹37.25 Cr | Open |
To see the full charge records of Ratnagene Lifescience Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Ratnagene Lifescience Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Ratnagene Lifescience Private Limited has 4 MSME Form 1 returns on record for the period ending Sep 2023, listing 20 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Rakesh Chemical Chhatral | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Ratnagene Lifescience Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Ratnagene Lifescience Private Limited has a workforce of 45 employees on its EPFO records as of Jun 2024, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2024-25 | 45 |
| FY 2023-24 | |
| FY 2022-23 |
To see the full employee and EPFO history of Ratnagene Lifescience Private Limited, buy the company report.
GST
Ratnagene Lifescience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AALCR2853E1ZF | Gujarat | Active | 03 Dec 2021 |
To see the full GST registrations and return filing status of Ratnagene Lifescience Private Limited, buy the company report.
Recent activity
Ratnagene Lifescience Private Limited has 8 board changes on record since 2021: 5 appointments and 3 cessations. The latest: Chetan Bipinchandra Shah ceased to be Additional Director on 08 Feb 2024.
2 earlier events are in the company report.
Frequently asked questions
Ratnagene Lifescience has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Ratnagene Lifescience was a private limited company based in Ahmedabad, Gujarat, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 15 September 2021 and is registered under CIN U24231GJ2021PTC125613. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Ratnagene Lifescience was incorporated on 15 September 2021. It is registered with the Registrar of Companies, Ahmedabad.
Ratnagene Lifescience had 5 directors:
- Swapnil Jatinbhai Shah - Director
- Chetan Bipinchandra Shah - Director
- Rishabh Mahendrakumar Sanghvi - Director
- Deval Rajnikant Shah - Director
- Vinay Khandelwal - Director
The CIN (Corporate Identification Number) of Ratnagene Lifescience is U24231GJ2021PTC125613. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Ratnagene Lifescience is at 1004 – 1006 10th Floor North Tower, Off. Ambli Road Opp. Ashok Vatika, Ahmedabad, Gujarat, India – 380054.
Ratnagene Lifescience can be reached through the website ratnagene.com. Its registered office is in Ahmedabad, Gujarat, India.
The latest financial statements of Ratnagene Lifescience on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Ratnagene Lifescience is 24AALCR2853E1ZF, registered in Gujarat.
Ratnagene Lifescience operated in the pharma industry, in the drug formulation and development segment.
The peers of Ratnagene Lifescience by revenue are Waruksha Laboratories Private Limited, Vidgas Science & Technologies Private Limited, Richcore Enzymes Private Limited, Tooba Pharmaceuticals Private Limited, Noven Life Sciences Private Limited and 1 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ratnagene Lifescience has 4 MSME Form 1 returns on record for the period ending Sep 2023, listing 20 overdue payments to 5 micro and small suppliers. The latest return was filed on 22 Nov 2023.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
